Source link : https://health365.info/the-function-of-glp-1-receptor-agonists-within-the-control-of-weight-problems/
Credit score: Unsplash/CC0 Public Area
As Australia faces a turning level in weight problems control, researchers from Monash College have contributed new insights into the all of a sudden evolving use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reminiscent of Ozempic within the Australian well being care device.
Initially advanced for sort 2 diabetes, GLP-1 RAs have won important traction globally for weight problems remedy. With 32% of Australians categorised as overweight in 2022 and the price of weight problems projected to succeed in $87.7 billion in Australia by way of 2032, a evaluate for the Scientific Magazine of Australia highlights the important wish to moderately plan how those drugs are used.
Affiliate Professor Suong Le, a gastroenterologist at Monash College’s College of Medical Sciences at Monash Well being and CEO of Juno Healthcare, is a senior creator at the evaluate.
“We’re at a watershed moment in obesity management. Because of how these new medications work, they’re transforming the way we view obesity as a condition,” Affiliate Professor Le stated. “It’s clear that obesity is not just a lifestyle choice, but should be regarded as a chronic inflammatory disease with links to cancer, brain function and autoimmune conditions.”
The evaluate used to be led by way of Dr. Chris Kanellis—a graduate of medication from Monash College and now a health care provider at Monash Well being—and carefully…
—-
Author : admin
Publish date : 2025-05-27 14:33:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8